UK

United Kingdom · Technology and data · C-Suite (20+ years)

Chief Bioinformatics Officer (CBO)

Here is the whole job, in plain words. What it is, what you decide, how you're judged, how people get here and where they go next. Then the part no course gives you: twelve AI tutors who learn your work.

See how AI is changing this job, and get the full read by email.

Start my free Automation Fluency module

As a Chief Bioinformatics Officer (CBO), a good place to start on Ethical AI Governance & Explainable AI (XAI) is Planning Automation Across a Department, a free Future Fluency module at Level 5. You'd practise working out what in your department's work could be automated, what should not be, and what to recommend.

Free to start, no card.

Keep this job description

Where should we send it?

One email: what AI is changing in this job, the new skills it asks for, where it leads, and where to start free. With a link back here. Nothing else follows unless you confirm your address.

Your employer, or 'self-employed'

Leading a team? Try this with up to five of them for 14 days, free.

  • Experience bandC-Suite (20+ years)
  • Reports toChief Executive Officer (CEO)
  • UK framework levelUsually an executive or board-level role

Also advertised as Chief Computational Biology Officer · Head of Enterprise Bioinformatics & Data Strategy · VP, Global Bioinformatics

Built on 43,079 real UK job descriptions we analysed · grounded in what real qualifications cover

Two short quizzes about you

1From this job to a course

The qualifications matched to this job

OTHM Level 7 Diploma in Data Science OTHM Qualifications · Level 7 · covers 3 of 8 standards
Level 6 Award in Data-led Decision Making Institute of Sales Professionals · Level 6 · covers 1 of 8 standards
Level 6 Certificate in Professional Sales Institute of Sales Professionals · Level 6 · covers 1 of 8 standards
Level 6 Diploma in Professional Sales Institute of Sales Professionals · Level 6 · covers 1 of 8 standards
TQUK Level 6 Diploma in Digital Leadership (RQF) Training Qualifications UK Ltd · Level 6 · covers 1 of 8 standards
Pearson BTEC Level 5 Higher National Diploma in Computing for England Pearson Education Ltd · Level 5 · covers 5 of 8 standards

Matched from the standards this job is measured against: a suggestion, not an official ruling.

The units you would start with

Data Science Foundations OTHM Level 7 Diploma in Data Science
Data-led Decision Making Level 6 Award in Data-led Decision Making
Data science TQUK Level 6 Diploma in Digital Leadership (RQF)
Advanced Programming for Data Analysis Pearson BTEC Level 5 Higher National Diploma in Computing for England

The future skills this job leans on

AI Fluency working with AI as a thinking partner
Data Fluency turning numbers into a decision
AI Governance Fluency using AI responsibly
Frontier Fluency the next wave, beyond mainstream AI
Change Fluency taking people through change
Your Plan Illustration

Built for Chief Bioinformatics Officer (CBO)

4 units that map to this job, from the qualifications that cover it.

  1. Data Science Foundations OTHM Qualifications · covers 3 of 8 standards Level 7
  2. Data-led Decision Making Institute of Sales Professionals · covers 1 of 8 standards Level 6
  3. Data science Training Qualifications UK Ltd · covers 1 of 8 standards Level 6
  4. Advanced Programming for Data Analysis Pearson Education Ltd · covers 5 of 8 standards Level 5
These are the real units behind this job, in the order they rank for it. Nothing here is marked done, because this plan has not been started by anyone yet. Yours would fill in as you go.

2AI and this work

Will AI change your work as a Chief Bioinformatics Officer (CBO)?

Nobody can say exactly how. Here is what this job is being asked for next, and where to start.

The new skills this role is being asked for

  • Ethical AI Governance & Explainable AI (XAI)
  • Decentralised Data Ecosystems & Web3 for Biomedical Data
Why each one is rising

The future skills this job leans on

We'll only ever tell you what we can actually back up. No hype, no scare tactics.

What happens when you start

Next, a free account. We build your Chief Bioinformatics Officer (CBO) plan as you set up, starting with the free Automation Fluency module. No card.

Your first Future Fluency module is free. After that, your AI tutor is £70 a month.

Ready to pay? Subscribe for £70 a month

Keep this read. One email with what AI is changing in this job, the new skills it asks for and where to start free. Nothing else follows unless you confirm your address.

3What this role really is

A Chief Bioinformatics Officer sets the direction for how data and computing are used to find new drugs. The role sits at executive level, shaping scientific direction and business decisions through data, and translating complex biological findings into terms the board and investors can act on.

4What you'd actually use

The tools this job runs on, and how well you'd need to know each one.

Python (ecosystem oversight) Strategic/Architect

Defining organisational standards for Python use, evaluating new libraries for strategic adoption, ensuring code quality and reproducibility frameworks are in place across all teams.

Genomic Analysis Suite (strategic selection) Strategic/Architect

Setting the enterprise strategy for standardising on specific genomic toolchains and versions, ensuring cross-project comparability, and navigating regulatory compliance for analytical methods.

Workflow Management (Nextflow/Snakemake strategy) Strategic/Architect

Architecting the enterprise workflow platform strategy, deciding on cloud execution engines, and ensuring all critical pipelines are robust, scalable, and reproducible.

Cloud Platforms (AWS/GCP enterprise strategy) Strategic/Architect

Defining the multi-cloud or hybrid-cloud strategy, managing enterprise-level security, and negotiating multi-million pound compute budgets with cloud providers. This is about cost-effectiveness and scalability.

Enterprise Data Platforms (Databricks, Snowflake, Terra.bio) Strategic/Architect

Leading the selection, implementation, and governance of enterprise-wide platforms for integrated multi-omics and clinical data analysis. This is critical for our data ecosystem.

Executive Reporting (Tableau Server, Power BI Premium, Diligent Boards) Expert

Overseeing the development of portfolio dashboards for executive and board review, and personally preparing high-stakes materials for the Scientific Advisory Board and Board of Directors. Clear, concise, and impactful communication is key.

5What you get to decide, and how that grows

Power in a job isn't your title. It's what you're allowed to decide. Here's how it grows as you move up.

The choiceComing in Where you are nowThe step above
Enterprise Bioinformatics Strategy & Roadmap N/A N/A N/A
P&L Management & Budget Allocation N/A N/A N/A
Organisational Design & Talent Strategy N/A N/A N/A
Strategic Partnerships & M&A N/A N/A N/A
External Representation & Thought Leadership N/A N/A N/A

6How you'll be judged

The scoreboard, and what is not on it. The hard targets, how often each is actually looked at, and the quiet signals that never reach a dashboard.

R&D Portfolio Acceleration
The average time it takes for a promising target to move from discovery to preclinical or clinical stages, directly attributable to bioinformatics insights.
Target · Reduce average time by 15% across the portfolio within 3 years.

Successfully identify and validate 3 new drug targets for oncology programmes, reducing the average discovery-to-IND timeline by 6 months, leading to a £50M valuation increase.

Computational Efficiency & Cost Optimisation
The overall efficiency of our computational infrastructure and resource use, measured against the R&D budget and scientific output.
Target · Maintain cloud compute and storage costs within 5% of forecast, while increasing computational throughput by 20% year-on-year.

Negotiate new cloud provider contracts and optimise internal workflows, saving £2M in compute costs annually while enabling two additional large-scale multi-omics studies.

Data Asset Value & FAIRness
The measurable value and reusability of our internal and external data assets, assessed by a 'FAIRness' index (Findable, Accessible, Interoperable, Reusable) and internal adoption rates.
Target · Increase our internal data FAIRness score by one full level (e.g., from 'Accessible' to 'Interoperable') within 2 years, and see 80% adoption of key data platforms by R&D teams.

Implement a new enterprise data catalogue and governance framework, leading to a 30% faster data retrieval for new projects and enabling a novel cross-disease analysis that wasn't possible before.

External Scientific & Market Recognition
Our company's standing in the scientific community and with investors, specifically for our bioinformatics capabilities.
Target · Secure 2+ high-impact scientific publications (Nature, Science, Cell) annually with bioinformatics as a lead component, and achieve a 10% increase in positive mentions by industry analysts regarding our data strategy.

Present our novel AI-driven drug discovery platform at a major industry conference, leading to a significant partnership inquiry and a positive analyst report highlighting our computational advantage.

Board and Investor Confidence
The level of trust and confidence the Board and investors have in our bioinformatics strategy and its ability to deliver long-term value.
  • Regularly invited to present strategic updates to the Board
  • investor calls frequently highlight bioinformatics as a key differentiator
  • positive feedback from Board members on strategic clarity and execution.
Scientific Leadership & Innovation
Our perceived leadership in the field of computational biology and our ability to attract top-tier talent.
  • Attracts top-tier bioinformatics talent from leading institutions
  • frequently cited in scientific literature
  • establishes strategic collaborations with leading academic groups
  • internal teams are consistently proposing and exploring novel computational approaches.
Cross-Functional Strategic Alignment
How well the bioinformatics strategy is integrated and supported across R&D, IT, and commercial functions.
  • Bioinformatics strategy is explicitly referenced in R&D and corporate strategic plans
  • joint initiatives with IT and R&D are common and successful
  • other executive leaders actively seek your input on strategic decisions.
Organisational Computational Maturity
The overall sophistication and effectiveness of our computational infrastructure, processes, and talent.
  • Successful implementation of enterprise-wide platforms
  • high adoption rates of new tools and methodologies
  • positive feedback from internal teams on the support and capabilities provided by the bioinformatics organisation
  • clear, measurable improvements in data governance and reproducibility.

7Would you like it

Both sides. What people enjoy, and what grinds them down.

What people enjoy
Shaping the Future of Medicine

You'll be constantly thinking about how our bioinformatics strategy can unlock new therapeutic modalities, accelerate drug development, and ultimately impact patient lives. This shows up in your relentless pursuit of novel computational approaches and your deep engagement with scientific breakthroughs.

Leading the strategic adoption of quantum computing for drug discovery, even if it's 5-10 years out, because you see the potential for transformative impact.

Building a World-Class Computational Organisation

You're driven by the challenge of attracting, developing, and retaining the absolute best bioinformatics and data science talent globally. You'll spend significant time on organisational design, mentorship programmes, and fostering a culture of innovation and scientific excellence.

Establishing a global bioinformatics fellowship programme that attracts top PhD graduates and positions the company as a leader in computational talent development.

Driving Enterprise Value through Data

You're motivated by the direct link between sophisticated data strategy and shareholder return. You'll be focused on how bioinformatics can de-risk R&D investments, identify new commercial opportunities, and enhance our competitive advantage in the market.

Presenting a clear ROI case to the Board for a multi-million pound investment in a new AI-driven target identification platform, directly linking it to projected increases in pipeline value.

What frustrates people
  • Navigating complex regulatory landscapes that can slow down innovative data approaches.
  • The constant battle for top-tier computational talent against tech giants with deeper pockets.
  • Overcoming organisational inertia or resistance to adopting new, transformative data-driven strategies.
  • Managing investor expectations that often demand immediate returns from long-term scientific investments.
  • Integrating disparate legacy systems and data silos across a global enterprise, a truly Herculean task.
  • The sheer scale of the 'bioinformatics hairball' across a large organisation, requiring strategic clean-up and standardisation.
What this role does not give you
  • A quiet, heads-down technical role; this is about leadership, strategy, and influence.
  • The luxury of avoiding difficult conversations with executive peers or the Board.
  • A predictable, stable environment; expect constant market shifts, scientific breakthroughs, and competitive pressures.
  • The ability to personally code every solution; your impact is through vision, team building, and strategic direction.

8Who you work with

This role directly shapes the company's scientific strategy, R&D portfolio, and ultimately, its market position and shareholder value. You'll be making decisions that affect multi-year investment cycles and the success of entire therapeutic areas. Frankly, your strategic vision for data will be a core differentiator for the entire business.

Inside the business
  • CEO and Executive Leadership Team
  • Board of Directors
  • Chief Scientific Officer (CSO) and R&D Leadership
  • Chief Technology Officer (CTO) and IT Leadership
  • Chief Financial Officer (CFO) and Finance Leadership
  • Legal and Regulatory Affairs
Outside the business
  • Investors and Analysts
  • Regulatory Bodies (e.g., MHRA, EMA)
  • Key Academic and Industry Partners
  • Scientific Advisory Board
  • Media and Public Relations

9What you need before you start

Not a wish list. The things you would be expected to already have.

  • A proven track record of 20+ years in bioinformatics or computational biology, with at least 5-7 years in senior executive leadership (VP/Director level) roles within a pharmaceutical or biotech company.
  • Demonstrable experience managing multi-million pound P&L responsibilities for a significant computational function.
  • Extensive experience building, leading, and mentoring large, multi-disciplinary global teams (100+ individuals, including managers).
  • A strong history of presenting complex scientific and technical strategies to Boards of Directors, investors, and regulatory bodies, securing significant buy-in and funding.
  • Deep expertise in at least two major therapeutic areas (e.g., Oncology, Neuroscience, Immunology) and their associated computational challenges.
  • A clear vision for how bioinformatics and AI will transform drug discovery and development over the next 5-10 years, and a track record of implementing that vision.

10What to practise next

Where the job is going, and what to do about it starting this week.

Quantum Computing for Drug Discovery (Strategic Oversight)

Long-term strategic importance (3-5+ years)—quantum computing isn't mainstream yet, but its potential to revolutionise molecular simulation, protein folding, and optimisation problems in drug discovery is immense. As CBO, you need to understand its trajectory and position the company to capitalise when it becomes viable.

Quantum algorithms for molecular dynamics · Quantum machine learning in bioinformatics · Hybrid quantum-classical computing · Quantum hardware limitations and roadmaps

  • This year: Establish a small 'future tech' working group to monitor quantum computing advancements.
  • Next 12 months: Fund a small academic collaboration to explore a quantum bioinformatics proof-of-concept.
  • Next 2 years: Develop a strategic roadmap for potential quantum computing integration, identifying key milestones.
  • Year 3: Consider strategic investments in quantum software or hardware startups if the technology matures.

Quick win: Encourage your leadership team to attend introductory webinars or read white papers on quantum computing in drug discovery. Just getting the concepts on their radar is a start.

11Staying current once you are in

What people here do to keep up
  • Regularly publish thought leadership articles in scientific and industry journals, positioning yourself and the company at the forefront of data-driven drug discovery.
  • Actively participate in and hold leadership positions within key industry consortia (e.g., Pistoia Alliance, TransCelerate BioPharma) to shape industry standards and best practices.
  • Serve on the advisory boards of relevant startups or academic institutions to stay connected to emerging technologies and talent.
  • Attend and speak at major global scientific and investor conferences (e.g., JP Morgan Healthcare Conference, AACR, ASHG) to represent the company and build strategic relationships.
  • Engage in continuous learning on global regulatory changes, ethical AI frameworks, and advanced business strategy through executive education programmes or peer groups.

12The rising capability

The rising capability

Zavmo analysis

What's rising in its place

This is where the work is heading, and the higher pay with it. Get fluent here and the shift stops being a threat and starts being your edge.

Ethical AI Governance & Explainable AI (XAI)

Critical within 12 months—regulators and the public are increasingly demanding transparency and accountability from AI systems, especially in healthcare. As AI becomes embedded in drug discovery, we need to ensure our models are not just powerful but also fair, unbiased, and understandable. This is a board-level concern.

  • AI bias detection and mitigation
  • Regulatory frameworks for AI in medicine
  • Model interpretability techniques (SHAP, LIME)
  • Data privacy in federated learning

Decentralised Data Ecosystems & Web3 for Biomedical Data

Important within 2-3 years—the future of biomedical data sharing might not be centralised. Technologies like blockchain, decentralised autonomous organisations (DAOs), and secure multi-party computation could revolutionise how we collaborate on data, manage patient consent, and incentivise data sharing. This could unlock massive new datasets.

  • Blockchain fundamentals for data provenance
  • Federated learning architectures
  • Tokenomics and data monetisation models
  • Digital identity and verifiable credentials

13What you’ll use

What you’ll use

Skills this role draws on

Technical

  • Enterprise NGS Data Strategy & Governance
  • Advanced Statistical Genetics for Portfolio Decisions
  • Machine Learning & AI for Market Prediction & Drug Discovery
  • Multi-Omics & Clinical Data Integration at Scale
  • Computational Reproducibility & Data FAIRness (Enterprise Level)

14The pathway

The pathway

How you actually get there, here

How you become one varies far more by country than what one does. This is the UK route. Most people take one of these ways in; the right one depends on where you're starting from.

  1. 1

    VP/SVP, Bioinformatics or Computational Biology (Large Pharma/Biotech)

    5-10 years at this level

    Skills to master

    • Managing multi-functional teams (100+), driving strategic initiatives for a therapeutic area or R&D function, P&L management, influencing executive leadership, building external partnerships.

    You're ready to move on when

    • Successfully led the computational strategy for multiple drug programmes from discovery to clinical stages.
    • Managed a significant budget (£5M+) and demonstrated clear ROI on computational investments.
    • Built and retained a high-performing leadership team within bioinformatics.
    • Consistently influenced R&D go/no-go decisions based on computational evidence.
    • Presented strategic updates to the Board or Executive Committee on a regular basis.
  2. 2

    Chief Scientific Officer (CSO) with Strong Computational Background

    3-7 years as CSO

    Skills to master

    • Overall R&D strategy, portfolio management, investor relations, deep scientific expertise across multiple disciplines, strong external scientific network, talent attraction at the most senior levels.

    You're ready to move on when

    • Led the scientific strategy for an entire company, driving significant pipeline advancements.
    • Successfully navigated regulatory interactions for novel scientific approaches.
    • Demonstrated strong investor communication skills, articulating scientific vision and progress.
    • Built a reputation as a scientific thought leader in the industry.
  3. 3

    Chief Technology Officer (CTO) from a Highly Data-Driven Biotech

    5-10 years as CTO

    Skills to master

    • Enterprise-level technology strategy, scalable infrastructure architecture, cybersecurity, software development lifecycle, managing large engineering teams, integrating technology with business objectives.

    You're ready to move on when

    • Successfully built and scaled the core technology platform for a data-intensive biotech company.
    • Managed large-scale cloud infrastructure and data platforms.
    • Demonstrated deep understanding of the intersection of technology, data, and biology.
    • Proven ability to attract and lead top-tier engineering and data talent.

15Where this role leads

The long view: This role sits near the top of the bioinformatics field. Decisions made here can shape how therapies are discovered, developed and delivered for years afterwards, and influence the wider direction of the industry.

The ten Future Fluencies

Zavmo analysis

The credential is what you can do today. These are what keep you valuable.

A qualification proves you can do the job as it's defined today. These ten are what decide whether you're still the obvious person for it in five years. They're the capabilities employers are now writing into senior roles faster than people are learning them. Zavmo weaves them through whatever you study, so you come out with both: the credential and the fluency.

The highlighted ones are the Fluencies your role leans on hardest, from how Chief Bioinformatics Officer (CBO) is actually changing.

Where it leads

Roles this leads to

The record names a next step, but the catalogue has no page for it yet:

  • Chief Executive Officer (CEO)
  • Board Member / Non-Executive Director (NED)

How you would learn this

One to one, on the work you already do

A tutor sets the task against your own job and marks the reasoning, at your pace. There is no cohort to fall behind.

A lesson from Data Science Foundations, worked against Chief Bioinformatics Officer (CBO).

Data Science Foundations Level 7

Applied to your work in Chief Bioinformatics Officer (CBO)

1. To enable the learner to define the scope and landscape of Data Science and differentiate the roles of Data Scientists from other IT professionals. 2. To enable the learner to evaluate key topics within Data Science, including data administration, governance, and big data sources. 3. To enable the learner to describe the architecture and core elements of Apache Hadoop. 4. To enable the learner to analyse the advantages and disadvantages of utilising Artificial Intelligence techniques in a business context. 5. To enable the learner to critically analyse the impact of Big Data on digital transformation within organisations and its effects on users. 6. To enable the learner to review strategies for ensuring data compliance and explain the responsibilities and challenges faced by data specialists.

How the thinking builds
  1. 1 Remember
  2. 2 Understand
  3. 3 Apply
  4. 4 Analyse
  5. 5 Evaluate
  6. 6 Create
An illustration of a Zavmo lesson, built from this role’s own route. The unit, its objective and every criterion above are the awarding body’s own words, not an example.

It is £70 a month, billed monthly. Your free first module is Future Fluency, and you can cancel any time.

See Your Progress Grow Illustration
Chief Bioinformatics Officer (CBO)
  • Enterprise NGS Data Strategy & Governance
  • Advanced Statistical Genetics for Portfolio Decisions
  • Machine Learning & AI for Market Prediction & Drug Discovery
  • Multi-Omics & Clinical Data Integration at Scale
  • Computational Reproducibility & Data FAIRness (Enterprise Level)
This is your Mind Palace on learn.zavmo.ai. Every skill above comes from this role's own record, not an example borrowed from another job. A node lights up when you evidence it, and what you build stays yours between jobs. That is the part a course cannot do.

16The detail, folded away

Everything else the record holds

The career branches in full, how AI is already showing up in the day-to-day, and the questions people ask about this job. Here when you want them, out of the way while you decide.

Where it leads next, rung by rung

Where it leads

The career path, and where it branches

Chief Bioinformatics Officer (CBO) is a start, not a ceiling. Each step below asks for new skills and hands back more autonomy.

  1. Chief Executive Officer (CEO)

    3-5 years as CBO

    Direct step up to lead the entire company.

    • P&L ownership for the entire enterprise
    • M&A strategy and execution (full accountability)
    • Public company leadership and external representation
    • Talent management across all functions

  2. Board Member / Non-Executive Director (NED)

    Immediately or within 1-2 years of CBO role

    Transition to governance and oversight, often across multiple companies.

    • Evaluating executive performance and compensation
    • Risk management and compliance oversight at the board level
    • Approving major strategic decisions and capital allocations
    • Providing independent oversight and challenge to executive management
Working with AI on the job

Working with AI

Where AI is starting to help

Honestly, at the C-suite level, your time is your most valuable asset. AI isn't here to replace your strategic brain, but to augment it, freeing you from the relentless tide of information and enabling deeper, more impactful decisions. Imagine having a personal AI chief of staff, constantly synthesising, analysing, and drafting on your behalf.

For a Chief Bioinformatics Officer, AI means moving beyond just automating pipelines. It's about using intelligent systems to gain unprecedented strategic insights, streamline executive communications, and even inform M&A decisions. We're talking about AI as a force multiplier for your leadership, allowing you to focus on the big picture and truly move the needle for the entire company.

Automated Strategic Synthesis

Use advanced LLMs and knowledge graphs to automatically synthesise vast amounts of internal R&D data, external scientific literature, and market intelligence. Get concise, actionable summaries on emerging therapeutic areas, competitive landscapes, and potential drug targets, tailored for executive review. This isn't just data; it's distilled wisdom.

AI-Powered Due Diligence & M&A

Employ AI to rapidly assess the computational assets, data quality, and bioinformatics talent of potential acquisition targets. Quickly identify integration challenges, IP risks, and synergistic opportunities in terabytes of data that would take human teams months to review. It's like having an army of data scientists on call for every deal.

Executive Communication AI

Fine-tune LLMs on your company's internal communications, board reports, and investor presentations. Generate first drafts of strategic memos, investor updates, and scientific white papers that perfectly align with your tone and messaging. Spend your time refining strategy, not wordsmithing. This is about making your voice heard, faster and clearer.

Predictive Market & Regulatory Intelligence

Deploy AI models to continuously monitor global regulatory changes, emerging ethical guidelines for AI in biology, and shifts in investor sentiment related to data-driven drug discovery. Get proactive alerts and synthesised reports, allowing you to anticipate challenges and position the company strategically. No more surprises from the market or regulators.

Common questions

Common questions

How do you become a Chief Bioinformatics Officer (CBO)?

Common routes in include VP/SVP, Bioinformatics or Computational Biology (Large Pharma/Biotech) (5-10 years at this level), Chief Scientific Officer (CSO) with Strong Computational Background (3-7 years as CSO) and Chief Technology Officer (CTO) from a Highly Data-Driven Biotech (5-10 years as CTO). Times vary with prior experience.

Where can a Chief Bioinformatics Officer (CBO) progress to?

This role can lead on to Chief Executive Officer (CEO) (3-5 years as CBO) and Board Member / Non-Executive Director (NED) (Immediately or within 1-2 years of CBO role), depending on the skills you build.

What new skills matter most for a Chief Bioinformatics Officer (CBO)?

Increasingly, Ethical AI Governance & Explainable AI (XAI) and Decentralised Data Ecosystems & Web3 for Biomedical Data. These are the skills our record of this role lists as growing.

Free tools

Want a read on where you stand?

Three free tools, no account needed. Each one ends with a role, a level and a way in.

Read the Zavmo manifesto to understand how you will be taught Meet your tutors

Or try another one

17Where to go from here

Other roles at Level 8

Same depth of qualification, different job. Useful if the work appeals but this particular role does not.

 More jobs in technology and data

Stay in the field you know and move sideways rather than up.
If you leave this industry

The skills built in this role carry across the life sciences sector. This includes large pharmaceutical companies, smaller biotechs, contract research organisations with data divisions, and health tech companies working in genomics or precision medicine. A strategic grasp of data makes this role useful in any organisation working on computational science.

This role profile is © 2026 Growth Engineering Technologies Ltd. Built from UK occupational standards and regulated qualification data, and written for Zavmo.

You're not behind. You're right on time. The shift is only just beginning. Your role won't look the same in two years. Be the one who leads the change, not the one it happens to. Start my free Automation Fluency module What happens next: a free account, then we build your plan as you set up. No card. Build your plan, see your roadmap and meet the twelve tutors matched to you. All free. When you're ready to start learning, it's £70 a month, billed monthly. Cancel any time and billing stops.